Teklab Gebregiworgis

Author

University Health Network ORCID

Also Known As

Ikura, Mitsuhiko, Teklab G. Gebregiworgis, Teklab Gebregiworgis

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University Health Network Princess Margaret Cancer Centre University of Toronto University of Nebraska–Lincoln University of Nebraska Medical Center

About

Teklab Gebregiworgis is an author at University Health Network specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	916
2	Cell Biology	4	4	793
3	Natural Sciences	1	1	35
4	Biochemistry	1	1	32
5	Cellular Physiology	1	1	18

Teklab Gebregiworgis

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer Surendra K. Shukla, Vinee Purohit, Kamiya Mehla, Cancer Cell Tumor BiologyImpart Gemcitabine ResistancePancreatic CancerOncogenic AgentMedicine	2017	531
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia Surendra K. Shukla, Teklab Gebregiworgis, Vinee Purohit, Cancer & Metabolism	2014	246
MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer Nina V. Chaika, Teklab Gebregiworgis, Michelle E. Lewallen, Proceedings of the National Academy of Sciences PathologyCancer BiologyTumor BiologyPancreatic CancerOncology	2012	232
Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation Yoshihito Kano, Teklab Gebregiworgis, Christopher B. Marshall, Nature Communications	2019	96
Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2–SP1–SAT1 axis Divya Murthy, Kuldeep S. Attri, Surendra K. Shukla, Nature Cell Biology	2024	65
A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica Teklab Gebregiworgis, Helle Hvilsted Nielsen, Chandirasegaran Massilamany, Journal of Proteome Research Neurological DisorderMetabolomic ProfilingOptic NerveBioanalysisClinical Diagnosis	2016	56
The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors Teklab Gebregiworgis, Yoshihito Kano, Jonathan St‐Germain, Nature Communications	2021	43
Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells Teklab Gebregiworgis, Vinee Purohit, Surendra K. Shukla, Journal of Proteome Research	2017	35
Oncogenic KRAS G12D mutation promotes dimerization through a second, phosphatidylserine–dependent interface: a model for KRAS oligomerization Kiyoung Lee, Masahiro Enomoto, Teklab Gebregiworgis, Chemical Science Proteinlipid InteractionMolecular BiologyMolecular GeneticsAnalytical UltracentrifugationLipid Movement	2021	35
Insights into gemcitabine resistance and the potential for therapeutic monitoring Teklab Gebregiworgis, Fatema Bhinderwala, Vinee Purohit, Metabolomics Therapeutic Drug MonitoringBiochemistryMedicineClinical PharmacologyPharmacotherapy	2018	32

Page 1